Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug 18;7(1):291.
doi: 10.1038/s41392-022-01126-4.

Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy

Evelyn Ullrich  1   2   3   4 , Meike Vogler  5 , Ivana von Metzler  6   7   8
Affiliations
Comment

Mitochondrial apoptosis: facilitator of NK cell-mediated immunotherapy

Evelyn Ullrich et al. Signal Transduct Target Ther. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Multi-step scenario of apoptosis-induction in cancer cells. Examples for efficient immune-oncology approaches combining ① tumor sensitizing agents, ② NK cell therapy and ③ NK cell activating strategies. This figure has been created with BioRender.com
See this image and copyright information in PMC

Comment on

References

    1. Pan R, et al. Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis. Cell. 2022;185:1521–1538 e1518. doi: 10.1016/j.cell.2022.03.030. - DOI - PMC - PubMed
    1. Liu E, et al. Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors. N. Engl. J. Med. 2020;382:545–553. doi: 10.1056/NEJMoa1910607. - DOI - PMC - PubMed
    1. Reindl LM, et al. Immunotherapy with NK cells: recent developments in gene modification open up new avenues. Oncoimmunology. 2020;9:1777651. doi: 10.1080/2162402X.2020.1777651. - DOI - PMC - PubMed
    1. Sarchen V, et al. Pediatric multicellular tumor spheroid models illustrate a therapeutic potential by combining BH3 mimetics with Natural Killer (NK) cell-based immunotherapy. Cell Death Discov. 2022;8:11. doi: 10.1038/s41420-021-00812-6. - DOI - PMC - PubMed
    1. Prager I, et al. NK cells switch from granzyme B to death receptor-mediated cytotoxicity during serial killing. J. Exp. Med. 2019;216:2113–2127. doi: 10.1084/jem.20181454. - DOI - PMC - PubMed

Publication types